
The Filtrate
Joel Topf @kidneyboy.bsky.social
Swapnil Hiremath @hswapnil.medsky.social
Nayan Arora captainchloride.bsky.social
Sopia Ambruso @sophia-kidney.bsky.social
Special Guests
Brendon Neuen @brendonneuen.bsky.social Associate Professor and Program Lead, Renal and Metabolic at The George Institute for Global Health. Nephrologist and Director of Kidney Trials at Royal North Shore Hospital.
Neuen has had three prior appearances on Freely Filtered: EMPA Kidney, DUPLEX and Sparsentan in FSGS, FLOW and Semaglutide
Muthiah Vaduganathan @mvaduganathan on X. Cardiologist at Brigham and Women's Hospital and Harvard Medical School. Assistant Professor of Medicine.
Editing by
Joel Topf
The Kidney Connection written and performed by Tim Yau
Show Notes
DONATE to NephJC!
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes NEJM | NephJC Summary
FIDELIO Bakris et al, NEJM 2020 | NephJC Summary; subgroup throws doubt on efficacy of finerenone in patients on flozins
FIGARO Pitt et al, NEJM 2021; subgroups clearly shows finerenone works, flozins or not
NEJM editorial (wrongly) saying do not use Flozins unless on RASi
Don’t use dual RAS blockade ONTARGET Yusuf et al, NEJM 2008; VA NEPHRON-D Fried et al NEJM 2013